Science & Technology
Enhancement of the Advanced Microphysiological Brain Injury Technology (AMBIT) into a Completely Xeno-Free Isogenic Multicellular Platform
Department of Defense — Air Force
Opportunity #: FA8649-24-P-0828
Award Ceiling
$110K
Award Floor
$110K
Close Date
Aug 19, 2024
Total Funding
$110K
Expected Awards
1
Posted Date
May 17, 2024
Cost Sharing Required
No
Grants.gov ID
sbir-FA8649-24-P-0828
Description
STTR Phase Phase I award: "Enhancement of the Advanced Microphysiological Brain Injury Technology (AMBIT) into a Completely Xeno-Free Isogenic Multicellular Platform" awarded to NANOMATRONIX in Fayetteville, Arkansas. Funded by Department of Defense (Air Force). Award amount: $109,835. The SBIR/STTR programs fund innovative research and development by small businesses, with Phase I for feasibility studies and Phase II for full R&D.
Eligible Applicants
Small businesses
Apply on Grants.gov
Always verify details and apply through the official Grants.gov portal. Information here may not reflect the latest changes.
View on Grants.govDisclaimer: This information is sourced from Grants.gov and may not reflect the most current details. Always verify eligibility requirements, deadlines, and application procedures on the official program website before applying.